Information:
Fel:
ID
21397
Beskrivning
NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Expanded PGx-Pharmacogenetic Research Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV
Nyckelord
Versioner (1)
- 2017-04-19 2017-04-19 -
Uppladdad den
19 april 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Genetic Screening For HLA-B*5701 in Patients with HIV Expanded PGx-Pharmacogenetic Research NCT00340080
Genetic Screening For HLA-B*5701 Expanded PGx-Pharmacogenetic Research NCT00340080
Similar models
Genetic Screening For HLA-B*5701 Expanded PGx-Pharmacogenetic Research NCT00340080
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Expanded PGx-Pharmacogenetic Research
C2347500 (UMLS CUI-1)
C0008976 (UMLS CUI-2)
C0008976 (UMLS CUI-2)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Has informed consent been obtained for expanded PGx-Pharmacogenetic research on safety/tolerability of HAART?
text
C0021430 (UMLS CUI [1])
Code List
Has informed consent been obtained for expanded PGx-Pharmacogenetic research on safety/tolerability of HAART?
CL Item
Yes (Y)
CL Item
No (N)
date informed consent obtained
Item
If Yes, record the date informed consent obtained for Expanded PGx-Pharmacogenetic research on safety/tolerability of HAART
date
C0514044 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
Item
If No, check one reason:
integer
C0392360 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator (2)
CL Item
Other (3)
reason informed consent not obtained
Item
If other reason please specify
text
C0392360 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
Item
Has subject withdrawn consent for expanded PGx-Pharmacogenetic research on safety/tolerability of HAART?
text
C1707492 (UMLS CUI [1])
Code List
Has subject withdrawn consent for expanded PGx-Pharmacogenetic research on safety/tolerability of HAART?
CL Item
Yes (Y)
CL Item
No (N)